Crispr Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.2M | 49k | 64.81 |
| 2025-03-31 | $2.8M | 84k | 34.03 |
| 2024-12-31 | $43M | 1.1M | 39.36 |
| 2024-09-30 | $29M | 624k | 46.98 |
| 2024-06-30 | $4.9M | 91k | 54.01 |
| 2022-12-31 | $2.6M | 65k | 40.65 |
| 2022-09-30 | $1.5M | 23k | 65.67 |
| 2022-03-31 | $440k | 7.0k | 62.71 |
| 2021-12-31 | $443k | 5.8k | 75.77 |
| 2021-09-30 | $1.2M | 11k | 111.90 |
| 2020-12-31 | $523k | 3.4k | 153.01 |
| 2020-09-30 | $8.3M | 100k | 83.64 |
| 2020-06-30 | $438k | 6.0k | 73.45 |
| 2019-06-30 | $5.2M | 110k | 47.10 |
| 2018-09-30 | $9.3M | 180k | 51.89 |
| 2018-06-30 | $24M | 416k | 58.76 |